Aligned with our findings, GPR21, which also had binding sites associated with the transcription factors, is expressively associated with developing type 2 diabetes, and it is a potential therapeutic target for its treatment [49]. The gene discussed is GPR21; the disease is type 2 diabetes mellitus.